Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 20, 2025VirusesOpen Access

Co-Detection of ADV, Influenza B, and HPIV: Independent Risk Factors for SMPP with Changes in NPIs

View Full Paper
Ask AI
Bookmark
Share

Authors

LHLinlin HuangTSTing Shi

Discussion

Loading...

Member takes

Overview

Retrospective analysis reveals independent risk factors for severe mycoplasma pneumoniae pneumonia in children, highlighting changes in NPIs.

Key Points

  • The co-detection rate of mycoplasma pneumoniae with other pathogens increased significantly after changes in NPIs.
  • Influenza B, human parainfluenza virus, and adenovirus were found as independent risk factors for severe mycoplasma pneumoniae pneumonia.
  • Older age and cancellation of NPIs also contributed to increased risk, alongside seasonal variations in the prevalence of infections.
  • The findings emphasize the importance of monitoring pathogen interactions in respiratory infections among children.

Cite This Study

Huang et al. (2025) studied this question.

synapsesocial.com/papers/68d43913713b0b5dfea791d8https://doi.org/10.3390/v17091266
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeted next-generation sequencing reveals pathogen mono- and co-detection patterns in pediatric Mycoplasma pneumoniae pneumonia2025
  2. 2Clinical features of MPP with or without viruses among hospitalized children in 2023, Wenzhou, Zhejiang, China2025
  3. 3Epidemiology and Clinical Impact of Mycoplasma pneumoniae in an Italian Pediatric Center: An Observational Study from 2017 to 20242025 · 6 citations
  4. 4Changes in <i>Mycoplasma pneumoniae</i> epidemiological and clinical features in children before, during, and after the COVID-19 pandemic in Shanghai, China2025 · 5 citations
  5. 5Changing patterns of respiratory pathogens in hospitalized children with community-acquired pneumonia in northern China following the lifting of non-pharmaceutical interventions2025